Cyclomydril Eye Solution

Cyclomydril Eye Solution is a solution with Cyclopentolate Hydrochloride and Phenylephrine Hydrochloride declared as its active content. It is supplied in a pack size of 5ml.

This is a non-prescription product and can be purchased without a prescription. Only product, safety and handling details are published on this page.

An online consultation with a DoctorOnCall doctor or pharmacist is available for this product, and a registered pharmacist reviews each order before dispatch to Malaysia or Singapore. Follow the directions on the label and on the leaflet inside the pack.

Cyclomydril Eye Solution is administered as eye drops directly into the eye(s) by, or under the direction of, an eye care professional, typically 1 drop instilled and repeated after a short interval if needed, according to the clinical protocol being followed. It is not intended for unsupervised self-administration, and patients should not adjust the dose or frequency themselves outside of the guidance provided during their clinic visit.

The exact number of drops and dosing interval for Cyclomydril Eye Solution is determined by the eye care professional based on the purpose of the examination or procedure and the individual’s response, commonly involving one drop in the eye(s) with an additional drop after 5 to 10 minutes if further dilation is required. Dosing in children may be adjusted with extra caution given their greater sensitivity to systemic absorption.

Cyclomydril Eye Solution typically has a shelf life of around 24 months from the date of manufacture when unopened and stored under recommended conditions, and a shorter in-use period once the bottle has been opened, as advised by the dispensing pharmacist or eye care provider. The expiry date printed on the bottle and carton should always be checked before use.

Store Cyclomydril Eye Solution below 25°C, away from direct light and heat, and keep the bottle tightly closed when not in use. Keep out of the reach and sight of children, and discard any remaining solution after the recommended in-use period following opening, as advised by the dispensing pharmacist.

Phenylephrine

Cyclopentolate

• Known hypersensitivity to cyclopentolate, phenylephrine, or any other ingredient in the solution
• Untreated narrow-angle or angle-closure glaucoma, or a known predisposition to angle closure
• Uncontrolled cardiovascular conditions, such as severe hypertension, where phenylephrine’s vasoconstrictive effect could pose additional risk
• Use with caution in infants, young children, and elderly patients due to increased sensitivity to systemic absorption

• Concurrent use with monoamine oxidase inhibitors (MAOIs) or tricyclic antidepressants may enhance the cardiovascular effects of phenylephrine
• Other sympathomimetic medications used at the same time may add to phenylephrine’s effects on heart rate and blood pressure
• Other anticholinergic medicines used systemically may add to cyclopentolate’s effects, increasing the likelihood of dry mouth, blurred vision, or other anticholinergic symptoms
• Inform the eye care professional of all other medications being taken, particularly heart or blood pressure medicines, before this solution is administered

• Arrange for someone to accompany you or avoid driving after the examination, as vision will be blurred and light sensitivity increased for several hours
• Wear sunglasses after the appointment to reduce discomfort from light sensitivity while the pupils remain dilated
• Inform the eye care professional of any heart conditions, high blood pressure, or glaucoma history before the solution is used
• Do not attempt to use this solution without professional supervision, as it is intended for administration during a clinical examination or procedure
• Contact the clinic promptly if severe eye pain, significant vision changes, or systemic symptoms occur after the appointment

Phenylephrine

Cyclopentolate

Cyclomydril Eye Solution is used within a clinical or hospital setting as part of a diagnostic eye examination or minor procedure rather than as a take-home daily medication, and its effects on pupil size and near vision are temporary but can last several hours after administration. Patients should plan their schedule around the temporary visual disturbance, particularly for activities such as driving or reading, and should raise any relevant medical history with their eye care professional beforehand.